CuraYou's ProWave Deep Healing Pad™ delivers red and infrared light therapy for multiple sclerosis in a medical-grade device designed for daily home use. The clinical and preclinical research behind red light therapy for multiple sclerosis is early but grounded in measurable biological effects: a placebo-controlled trial documented real strength gains, a meta-analysis of animal studies found reduced disease severity, and human-cell experiments confirmed that immune cells from people with MS respond to red and near-infrared light. Translating that research into something a person with MS can actually use at home requires specific wavelengths, adequate power, consistent dosing, and a device that is safe for unsupervised daily use. This article covers exactly how the Cura ProWave Deep Healing Pad™ meets those requirements: which wavelengths it delivers, why it uses LEDs rather than lasers, how much power reaches the tissue, and what treatment routine CuraYou recommends.
Part of our complete guide to Red and Infrared Light Therapy for Multiple Sclerosis.
Key Takeaways
- The wavelengths match the research. The Cura ProWave Deep Healing Pad™ delivers 850 nm near-infrared light from 240 light chips and 660 nm red light from 120 light chips, 360 in total, at 200 mW/cm² across an 18 × 8 inch flexible pad. Both wavelengths sit within the ranges studied in the MS literature: 660–670 nm for cellular energy restoration and immune modulation, and 830–850 nm near-infrared for deeper tissue penetration and anti-inflammatory effects documented in human immune-cell experiments.
- LED arrays offer practical advantages over clinical lasers for daily home use. The biological response to light depends on wavelength and dose, not the device type. Heiskanen and Hamblin (2018) concluded that photobiomodulation does not depend on lasers or coherence. An LED pad covers a large treatment area at once, requires no trained operator, and is safe for unsupervised daily use which matters for a condition that demands consistency over weeks and months.
- Consistent daily use is the protocol the research rewards. CuraYou recommends daily 20-minute sessions using the pre-set modes, aligned with the treatment courses in MS studies that ranged from daily to multiple sessions per week over several weeks. The device comes with a guided routine and progress tools to build the kind of consistency that separates effective treatment from occasional use.
What the Research Requires
How Red and Infrared Light Therapy May Help Multiple Sclerosis
Red and infrared light therapy (photobiomodulation) works through several biological pathways relevant to MS. Red light at 660–670 nm is absorbed by cytochrome c oxidase, the enzyme in the mitochondrial energy chain that drives the cellular response. A foundational neuron study by Wong-Riley and colleagues (2005) established that 670 nm and 830 nm light restored energy production in neurons after metabolic toxins had shut it down, and that the effective wavelengths matched the absorption pattern of this enzyme. That cellular energy mechanism is directly relevant to MS, where damaged myelin forces nerve fibers to work harder at the same time that inflammation and oxidative stress impair the structures producing their energy.
The MS-specific research divides across several pathways. A 2024 meta-analysis by Ahmed pooled three animal studies and found that photobiomodulation reduced disease severity by 1.44 points on the 0–5 scale used to score mice (95% CI −2.45 to −0.42, p = 0.006), alongside less immune-cell infiltration, less myelin loss, and fewer cell-death markers. Human-cell experiments by Tolentino, Cho, and Lyons (2022) showed that immune cells drawn from people with MS responded to 670 nm and 830 nm light with shifts toward anti-inflammatory signaling. And the strongest human trial, a randomized double-blind crossover study of 17 people with MS by Rouhani and colleagues (2024), found significant gains in muscle strength and force recovery after fatiguing exercise — measured with a dynamometer, not a questionnaire. For the full evidence, see the complete guide to red light therapy for multiple sclerosis.
Wavelength, Dose, and Protocol Parameters
For any device to deliver these effects, the research points to specific requirements. The most repeated wavelength in the MS animal literature is 670 nm, close to the 660 nm red light the Cura ProWave Deep Healing Pad delivers. Human MS studies have used 808 nm, 830 nm, and 850 nm in the near-infrared range, all within the band where cytochrome c oxidase absorbs light and where deeper tissue penetration occurs. Hamblin (2017) established that the biological effects of photobiomodulation depend on wavelength, dose, and intensity, with a biphasic dose response in which both too little and too much light reduce the effect.
The human MS trials used treatment courses ranging from a single session to 24 sessions over several weeks. The Rouhani crossover trial delivered individualized dosing over two weeks and measured significant strength gains. The small uncontrolled trial by Silva and colleagues (2020) found changes in immune signaling after 24 sessions. No standardized consumer protocol exists for MS, and the field has not yet determined which combination of wavelength, dose, site, and schedule produces the best outcomes. What the research does establish is that adequate power matters, underdosed treatments fail and that consistent, repeated sessions produce the measurable effects reported in the studies.
The therapy carries a reassuring short-term safety record. A 2024 systematic review by Oliveira de Andrade Filho and colleagues found no adverse effects across eight included MS-related studies. A 2025 umbrella review by Son and colleagues supports photobiomodulation as a non-invasive, well-tolerated therapy across multiple conditions. That said, long-term safety and interactions with MS disease-modifying therapies have not been adequately studied, so anyone taking MS medication should discuss light therapy with their neurologist before starting. The effectiveness of the therapy depends on delivering the right wavelengths at enough power with consistent use, parameters that vary widely across consumer devices.
The research on photobiomodulation for MS is still early, but the biological rationale is strong and getting stronger. The cellular energy pathway is established, the anti-inflammatory effects have been measured in immune cells from MS patients, and the Rouhani trial gave us objective muscle data rather than subjective scores. When a patient asks me what matters in a home device, I tell them the same thing: the right wavelengths, adequate power, and a routine they will actually stick with every day. Those are the factors that separate something that works from something that sits in a drawer.— Dr. William Carter, MD
Why the Cura ProWave Deep Healing Pad™ Uses LEDs Instead of Lasers
Most of the published MS research used professional lasers in clinical or laboratory settings. If the evidence base used lasers, why does the Cura ProWave Deep Healing Pad™ use LEDs?
The Biology Does Not Require a Laser
The cellular response to light depends on the wavelength and the dose delivered to tissue, not on whether the photon came from a laser or an LED. A photon at 660 nm triggers the same interaction with cytochrome c oxidase regardless of its source. Hamblin (2017) established that the biological effects depend on wavelength, dose, and intensity, not on the laser-versus-LED distinction. The most thorough peer-reviewed analysis of this question, by Heiskanen and Hamblin (2018) of Massachusetts General Hospital and Harvard, concluded that photobiomodulation does not depend on lasers or coherence, and that LED therapy appears as effective as laser therapy for surface-tissue applications at matched wavelength and dose. A 2025 comprehensive review by Martins and colleagues confirmed that LEDs can deliver comparable photobiomodulatory outcomes when intensity and dose parameters are matched, despite their broader emission pattern.
LED Covers a Larger Treatment Area
MS affects multiple sites: the spinal cord, the brain, peripheral muscles, and the nerves that connect them. A clinical laser treats one small point at a time and needs a trained operator to move the probe across the target area. An LED array built into a flexible pad covers a broad surface in one session. For the muscle-function application supported by the Rouhani trial, that means treating the full muscle group rather than a single point. For the broader anti-inflammatory and cellular energy pathways documented in the research, broad coverage ensures more tissue receives an effective dose per session.
LED Makes Daily Home Use Possible
The MS studies reporting the strongest effects used repeated sessions over weeks. The Silva trial administered 24 sessions. The Rouhani trial delivered daily individualized treatment over two weeks. Clinical laser sessions require a clinic visit each time, administered by trained staff which is impractical to sustain daily over months, especially for people whose MS symptoms make travel difficult. A home LED device enables the kind of consistent daily routine the research rewards, without requiring specialized training or supervision.
Safe for Unsupervised Use
The lasers used in clinical photobiomodulation research are Class 3B or higher medical devices that can damage the eyes on direct exposure and require trained operators and protective eyewear. LED devices operate at power levels that do not carry those risks. The Cura ProWave Deep Healing Pad™ is FDA Registered and ISO Certified, with 0 V/m EMF output, so it can be used safely at home without the supervision a clinical laser requires. For a condition like MS where daily consistency matters, removing barriers to use is not a convenience feature. It determines whether the treatment happens at all.
How the Cura ProWave Deep Healing Pad™ Delivers Light Therapy
Wavelengths
The Cura ProWave Deep Healing Pad™ is built around 120 medical-grade triple-chip LEDs: 240 light chips emitting near-infrared at 850 nm and 120 light chips emitting red at 660 nm. Both wavelengths sit within the ranges studied in the MS research. The 660 nm red light falls in the band where cytochrome c oxidase absorbs light most effectively, the same range as the 670 nm wavelength used across the MS animal studies (Muili et al., 2013; Gonçalves et al., 2016; Ahmed, 2024) and the foundational neuron study by Wong-Riley and colleagues (2005). The 850 nm near-infrared sits within the range where human-cell experiments on MS immune cells found measurable anti-inflammatory effects (Tolentino, Cho, and Lyons, 2022), and where deeper tissue penetration occurs to reach muscles, nerves, and structures closer to the spine.
Power Density: Why It Matters
The Cura ProWave Deep Healing Pad™ delivers 200 mW/cm², among the highest power densities available in a home-use LED device. Power density determines how much light energy reaches each patch of skin and therefore how much energy penetrates to the underlying tissue. This matters because the MS research, like photobiomodulation research more broadly, follows a dose-dependent pattern. Hamblin (2017) documented the biphasic dose response: too little light produces no measurable effect, while an adequate dose activates the cellular response. Light loses intensity as it passes through skin, fat, and muscle, so the energy at the target tissue is always less than the energy at the surface. Higher surface power gives more energy a chance to reach deeper targets, i.e. the muscles where the Rouhani trial measured its strength gains, and the tissue layers relevant to the anti-inflammatory and energy pathways documented in the broader MS literature.
Flexible Coverage for Different Treatment Sites
The pad measures 18 × 8 inches, large enough to wrap around the thigh, the lower back and spinal area, the shoulders, or other regions depending on where symptoms present. MS symptoms vary between individuals and over time. Weakness in the legs one month, spasticity in the trunk the next. The flexible neoprene design and strap system allow the pad to conform to different body contours and be repositioned without help, which is particularly important for people with MS who may have limited grip strength or mobility. Where clinical laser protocols require a practitioner to move a probe point by point, the Cura ProWave Deep Healing Pad™ treats a full area at once.
Three Treatment Modes
The device runs in three modes: red only (660 nm), infrared only (850 nm), and combined. Red light works on surface tissue, addressing inflammation in superficial muscles and the cellular energy response documented in the Wong-Riley research. Infrared reaches deeper tissue in muscles, nerves, and structures that sit beneath multiple tissue layers. Combined mode delivers both wavelengths simultaneously, covering both the surface and deeper pathways in one session. The MS research used both red (660–670 nm) and near-infrared (808–850 nm) wavelengths across different studies, and the ability to run each separately or together means treatment can be matched to the situation: combined mode as the default for addressing both energy and inflammatory pathways, infrared mode when deeper muscle function is the focus.
Pre-Set Modes and Guided Routine
The Cura ProWave Deep Healing Pad™ includes pre-set modes with parameters designed to land within the effective dosing range, removing the guesswork that undermines generic devices. Photobiomodulation follows a biphasic dose response where both too little and too much reduce the effect (Hamblin, 2017), so the pre-sets keep treatment in the therapeutic window. The device also comes with a cellular restoration protocol and progress tools to help build a daily habit and track response over time. For MS specifically, this matters: the Rouhani trial and the Silva trial both required multiple consistent sessions before measurable effects appeared. A device used occasionally will not reproduce what those studies achieved. Consistency is not a bonus, it is a requirement.
CuraYou's Recommended Routine for Multiple Sclerosis
Based on the research parameters and the biological pathways involved, CuraYou recommends daily 20-minute sessions in the combined red-and-infrared mode as the starting routine. For muscle weakness and fatigue (the outcomes with the strongest human evidence) the pad is applied directly over the affected muscle groups. For broader anti-inflammatory and cellular energy support, the pad can be positioned along the spine or across larger muscle areas. CuraYou's human support team can help tailor the routine to individual symptoms and treatment goals, since someone dealing primarily with leg weakness and someone managing spasticity in the upper body may do best with different placement and mode settings.
Medical-Grade Quality and Real Support
The Cura ProWave Deep Healing Pad™ is FDA Registered and ISO Certified, with precise wavelengths within the documented therapeutic ranges. Its 0 V/m EMF rating means no electromagnetic field exposure during treatment, and the LEDs are rated for 50,000 hours, holding their output across years of daily use. It can be purchased with an HSA or FSA card and is backed by up to a 3-year warranty. CuraYou provides real human support to help tailor your routine and answer questions. Not chatbots, not generic FAQs. Hundreds of verified customer reviews document the results people report from consistent use.
Conclusion
The Cura ProWave Deep Healing Pad™ takes the research behind red and infrared light therapy for multiple sclerosis and builds it into a medical-grade device made for daily home use. Its 660 nm red and 850 nm near-infrared LEDs sit within the wavelength ranges studied across the MS literature, from the foundational neuron experiments to the human crossover trial that measured real strength gains. Its 200 mW/cm² power density is built to deliver the kind of dosing the research shows is needed, and its 120-LED, 18 × 8 inch flexible pad treats a full area at once rather than one point at a time. The MS research is early, and no standardized consumer protocol exists. What does exist is a connected body of evidence (animal, human-cell, and clinical) pointing to cellular energy, anti-inflammatory signaling, and muscle function as the pathways where light therapy may complement standard medical care, under a neurologist's guidance. Most of the human MS studies showing measurable effects delivered treatment over 4 weeks of consistent daily use, a timeline that fits within CuraYou's 60-day risk-free return guarantee. That gives you time to follow the protocol, observe your response, and decide or receive a full refund.
